Non-Invasive Glucose-Monitoring Market Size

Non-Invasive Glucose Monitoring Devices Market size was valued at USD 27.03 million in 2023 and is poised to reach USD 354.73 million by the end of 2036, registering around 21.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of non-invasive glucose monitoring devices is assessed at USD 31.77 million.

Extensive research associated with diabetes management globally, along with the growing investment in the development of advanced monitoring systems are expected to fuel the progress of this market in the future. The growth of the market can also be attributed to factors such as the increasing geriatric population and the rising prevalence of diabetes mellitus amongst individuals on a global level. According to the data collected from The International Diabetes Federation (IDF), in 2019, 463 million estimated number of adults aged between 20-79 years were suffering from diabetes and by 2045, the number is expected to rise to 700 million.

Frequently Asked Questions (FAQ)

Rising prevalence of diabetes mellitus and increasing elderly population are the key factors driving market growth.

The market is anticipated to attain a high CAGR over the forecast period, i.e., 2021-2029.

Costly non-invasive glucose-monitoring devices and lack of accuracy and sensitivity are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing awareness about non-invasive glucose-monitoring systems.

The major players dominating the Non-Invasive Glucose-Monitoring market are DiaMonTech AG, Nemaura Medical, Metamaterial Inc., BOYDSense SAS, LifePlus, Inc., Cnoga Medical Ltd., among others.

Non-Invasive Glucose-Monitoring Market Size